help button home button Am J Pathol Epitomics Buy 2 Antibodies Get 1 Free Special Offer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kitamura, H.
Right arrow Articles by Ohkawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kitamura, H.
Right arrow Articles by Ohkawa, H.

American Journal of Pathology, Vol 147, 1682-1692, Copyright © 1995 by American Society for Investigative Pathology


REGULAR ARTICLES

Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. A cellular relationship among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in bone marrow

H Kitamura, H Kawata, F Takahashi, Y Higuchi, T Furuichi and H Ohkawa
Fuji-Gotemba Research Laboratory, Chugai Pharmaceutical Co., Shizuoka, Japan.

To elucidate the effect of interleukin-6 (IL-6) on bone and bone marrow (BM), human IL-6 transgenic mice (hIL-6 tgm) were produced. Their bone and BM were examined histologically, radiologically, histomorphometrically, and hematologically on a temporal basis. hIL-6 tgm showed histologically evident neutrophilia in BM. Increase in precursors of granulocytes and monocytes in hIL-6 tgm was demonstrated by an assay for colony forming unit in culture (CFU-C) of BM cells. Decrease in osteoblasts and osteoid and suppression of primary spongiosa formation were predominantly observed in hIL-6 tgm at 14 weeks old, the terminal stage of life for hIL-6 tgm. An assay for colony forming unit in fibroblastic (CFU-F) of BM cells revealed a decrease in osteoblast precursor (with regard to alkaline phosphatase- positive colonies) in hIL-6 tgm at 15 weeks old. Histomorphometry demonstrated a decrease of both osteoclast number and bone resorption in hIL-6 tgm. These results suggested that enhanced granulocytic hematopoiesis, suppressed bone turnover, and alteration of cellular population in stromal cells in BM occurred in hIL-6 tgm. Thus we provide new findings that facilitate understanding of cellular interrelationships among hematopoietic cells, osteoblasts, and osteoclasts mediated by stromal cells in BM.


This article has been cited by other articles:


Home page
EndocrinologyHome page
L. Duplomb, M. Baud'huin, C. Charrier, M. Berreur, V. Trichet, F. Blanchard, and D. Heymann
Interleukin-6 Inhibits Receptor Activator of Nuclear Factor {kappa}B Ligand-Induced Osteoclastogenesis by Diverting Cells into the Macrophage Lineage: Key Role of Serine727 Phosphorylation of Signal Transducer and Activator of Transcription 3
Endocrinology, July 1, 2008; 149(7): 3688 - 3697.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Yoshitake, S. Itoh, H. Narita, K. Ishihara, and S. Ebisu
Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-{kappa}B Signaling Pathways
J. Biol. Chem., April 25, 2008; 283(17): 11535 - 11540.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Chung, J. C. Cool, M. A. Scherer, B. K. Foster, and C. J. Xian
Roles of neutrophil-mediated inflammatory response in the bony repair of injured growth plate cartilage in young rats
J. Leukoc. Biol., December 1, 2006; 80(6): 1272 - 1280.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. A. O'Brien, R. L. Jilka, Q. Fu, S. Stewart, R. S. Weinstein, and S. C. Manolagas
IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice
Am J Physiol Endocrinol Metab, November 1, 2005; 289(5): E784 - E793.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
A. Teti
New Concepts in Osteoclast Pathophysiology
IBMS BoneKEy, June 1, 2005; 2(6): 17 - 22.
[Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. E. Compston
Sex Steroids and Bone
Physiol Rev, January 1, 2001; 81(1): 419 - 447.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
V. A. Luyckx, B. Leclercq, L. K. Dowland, and A. S. L. Yu
Diet-dependent hypercalciuria in transgenic mice with reduced CLC5 chloride channel expression
PNAS, October 12, 1999; 96(21): 12174 - 12179.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Yoshitake, S. R. Rittling, D. T. Denhardt, and M. Noda
Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption
PNAS, July 6, 1999; 96(14): 8156 - 8160.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T Laitala-Leinonen, C Lowik, S Papapoulos, and H. Vaananen
Inhibition of intravacuolar acidification by antisense RNA decreases osteoclast differentiation and bone resorption in vitro
J. Cell Sci., January 11, 1999; 112(21): 3657 - 3666.
[Abstract] [PDF]


Home page
EndocrinologyHome page
R. Pacifici
Editorial: Cytokines, Estrogen, and Postmenopausal Osteoporosis--The Second Decade
Endocrinology, June 1, 1998; 139(6): 2659 - 2661.
[Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kawasaki, Y.-H. Gao, S. Yokose, Y. Kaji, T. Nakamura, T. Suda, K. Yoshida, T. Taga, T. Kishimoto, H. Kataoka, et al.
Osteoclasts Are Present in gp130-Deficient Mice
Endocrinology, November 1, 1997; 138(11): 4959 - 4965.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society for Investigative Pathology.